
- Home
- Companies
- Kheiron Medical Technologies Limited
- Software
- MiaTriage - Double Reader Software ...
MiaTriage - Double Reader Software Solution
Mia® is our breakthrough AI platform for breast screening. A suite of solutions, Mia empowers radiologists and screening services to deliver confident, accurate and timely results to every woman, everywhere.
Discover how Mia delivers gold-standard quality and performance for double reader triage, increasing efficiency by automating up to 25% of your reading workflow.
Mia® Triage is part of our Mia® solution, which is CE marked for sale in the EU and UK. Mia has TGA approval in Australia and Medsafe registration in New Zealand. Mia is commercially available in the UAE and Qatar pending local registration.
The workforce crisis
With fewer staff and a falling number of radiologists, there’s more work to do for those who are trained to read mammograms. Even though they’re already stretched beyond capacity.
Fatigue and burnout
Higher workloads and tackling new ways of working has led to widespread fatigue, with 61% of US radiologists rating their anxiety levels at 7/10 or more.*
High image volumes
The volume of images needing to be read continues to increase because of the size of screening populations, efforts to clear backlogs – which have been exacerbated by Covid, and imaging modalities.
Delivering ground-breaking performance for radiologists, providers and women alike
With patient safety and clinical rigour at the heart of our mission, we’re making sure Mia is the best-performing AI software in breast cancer screening for everyone involved.
For Radiologists
Help radiologists increase their productivity and accuracy with a solution that’s reducing the number of missed cancers as well as lowering false positives.
For providers
Give back control to your radiology departments by increasing standardisation, mitigating radiologist shortages and gaining immediate cost savings.
For women
Build greater trust with women by putting them at ease with more reliable cancer detection. So you can both avoid unnecessary biopsies and reduce recall anxiety.